Skip to main content

Table 2 Progression of vitreous hemorrhage score during the study in Group A

From: Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: a randomized clinical trial

Group A

Baseline

After 1st IVB (8 Weeks)

After 2nd IVB (16 Weeks)

After 3rd IVB (24 Weeks)

Grade 0

0

2

8

21

Grade 1

3

6

17

8

Grade 2

14

18

7

4

Grade 3

18

9

3

2

  1. IVB intravitreous bevacizumab injection
Back to article page

International Journal of Retina and Vitreous

ISSN: 2056-9920

Contact us